Cephalexin-induced acute generalized exanthematous pustulosis

Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associat...

Full description

Saved in:
Bibliographic Details
Published in:Dermatology reports 2018-10, Vol.10 (2)
Main Authors: DaCunha, Matthew, Moore, Sarah, Kaplan, David
Format: Article
Language:English
Subjects:
Antibiotic
Case Report
Drug reaction
Erythematous
Pustular eruption
Tender
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-1fa13034581ea540bb94760ef201f58659e06e6e9db04d2799767c45d30251063
cites
container_end_page
container_issue 2
container_start_page
container_title Dermatology reports
container_volume 10
creator DaCunha, Matthew
Moore, Sarah
Kaplan, David
description Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.
doi_str_mv 10.4081/dr.2018.7686
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8d7a89a3c37548f597bdca4131c65402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8d7a89a3c37548f597bdca4131c65402</doaj_id><sourcerecordid>2438734735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-1fa13034581ea540bb94760ef201f58659e06e6e9db04d2799767c45d30251063</originalsourceid><addsrcrecordid>eNpVkU1LJDEQhoO4qLje9gcMeLXHSuf7oCCD7gqCl91zSCfVMz30dMakW9Rfb2ZHBetSRVXxvFW8hPyiMOeg6WVI8xqoniup5QE5qYHJSnGQh581M_UxOct5DSUYo1TRI3LMgEuuwZyQqwVuV67Hl26ouiFMHsPM-WnE2RIHTK7v3koHX9wwrnDjxjjl2XbK49TH3OWf5Efr-oxnH_mU_Lu7_bv4Uz08_r5f3DxUnis9VrR1lAHjQlN0gkPTGK4kYFtub4WWwiBIlGhCAzzUyhglleciMKgFBclOyf2eG6Jb223qNi692ug6-78R09K6NHa-R6uDcto45pkSXLfCqCZ4xymjXhbpurCu96zt1GwweBzG8uY36PfJ0K3sMj5bWYPSAgrg_AOQ4tOEebTrOKWh_G9rzrRiXDFRti72Wz7FnBO2XwoU7M47G5LdeWd33rF3l0SJqA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2438734735</pqid></control><display><type>article</type><title>Cephalexin-induced acute generalized exanthematous pustulosis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>DaCunha, Matthew ; Moore, Sarah ; Kaplan, David</creator><creatorcontrib>DaCunha, Matthew ; Moore, Sarah ; Kaplan, David</creatorcontrib><description>Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.</description><identifier>ISSN: 2036-7392</identifier><identifier>EISSN: 2036-7406</identifier><identifier>DOI: 10.4081/dr.2018.7686</identifier><identifier>PMID: 30464809</identifier><language>eng</language><publisher>Pavia: PAGEPress Publications</publisher><subject>Antibiotic ; Case Report ; Drug reaction ; Erythematous ; Pustular eruption ; Tender</subject><ispartof>Dermatology reports, 2018-10, Vol.10 (2)</ispartof><rights>2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright M. DaCunha et al., 2018 2018 Licensee PAGEPress, Italy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-1fa13034581ea540bb94760ef201f58659e06e6e9db04d2799767c45d30251063</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207850/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2438734735?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793</link.rule.ids></links><search><creatorcontrib>DaCunha, Matthew</creatorcontrib><creatorcontrib>Moore, Sarah</creatorcontrib><creatorcontrib>Kaplan, David</creatorcontrib><title>Cephalexin-induced acute generalized exanthematous pustulosis</title><title>Dermatology reports</title><description>Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.</description><subject>Antibiotic</subject><subject>Case Report</subject><subject>Drug reaction</subject><subject>Erythematous</subject><subject>Pustular eruption</subject><subject>Tender</subject><issn>2036-7392</issn><issn>2036-7406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpVkU1LJDEQhoO4qLje9gcMeLXHSuf7oCCD7gqCl91zSCfVMz30dMakW9Rfb2ZHBetSRVXxvFW8hPyiMOeg6WVI8xqoniup5QE5qYHJSnGQh581M_UxOct5DSUYo1TRI3LMgEuuwZyQqwVuV67Hl26ouiFMHsPM-WnE2RIHTK7v3koHX9wwrnDjxjjl2XbK49TH3OWf5Efr-oxnH_mU_Lu7_bv4Uz08_r5f3DxUnis9VrR1lAHjQlN0gkPTGK4kYFtub4WWwiBIlGhCAzzUyhglleciMKgFBclOyf2eG6Jb223qNi692ug6-78R09K6NHa-R6uDcto45pkSXLfCqCZ4xymjXhbpurCu96zt1GwweBzG8uY36PfJ0K3sMj5bWYPSAgrg_AOQ4tOEebTrOKWh_G9rzrRiXDFRti72Wz7FnBO2XwoU7M47G5LdeWd33rF3l0SJqA</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>DaCunha, Matthew</creator><creator>Moore, Sarah</creator><creator>Kaplan, David</creator><general>PAGEPress Publications</general><general>PAGEPress Publications, Pavia, Italy</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20181001</creationdate><title>Cephalexin-induced acute generalized exanthematous pustulosis</title><author>DaCunha, Matthew ; Moore, Sarah ; Kaplan, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-1fa13034581ea540bb94760ef201f58659e06e6e9db04d2799767c45d30251063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibiotic</topic><topic>Case Report</topic><topic>Drug reaction</topic><topic>Erythematous</topic><topic>Pustular eruption</topic><topic>Tender</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DaCunha, Matthew</creatorcontrib><creatorcontrib>Moore, Sarah</creatorcontrib><creatorcontrib>Kaplan, David</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Dermatology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DaCunha, Matthew</au><au>Moore, Sarah</au><au>Kaplan, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cephalexin-induced acute generalized exanthematous pustulosis</atitle><jtitle>Dermatology reports</jtitle><date>2018-10-01</date><risdate>2018</risdate><volume>10</volume><issue>2</issue><issn>2036-7392</issn><eissn>2036-7406</eissn><abstract>Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.</abstract><cop>Pavia</cop><pub>PAGEPress Publications</pub><pmid>30464809</pmid><doi>10.4081/dr.2018.7686</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2036-7392
ispartof Dermatology reports, 2018-10, Vol.10 (2)
issn 2036-7392
2036-7406
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8d7a89a3c37548f597bdca4131c65402
source Publicly Available Content Database; PubMed Central
subjects Antibiotic
Case Report
Drug reaction
Erythematous
Pustular eruption
Tender
title Cephalexin-induced acute generalized exanthematous pustulosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A52%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cephalexin-induced%20acute%20generalized%20exanthematous%20pustulosis&rft.jtitle=Dermatology%20reports&rft.au=DaCunha,%20Matthew&rft.date=2018-10-01&rft.volume=10&rft.issue=2&rft.issn=2036-7392&rft.eissn=2036-7406&rft_id=info:doi/10.4081/dr.2018.7686&rft_dat=%3Cproquest_doaj_%3E2438734735%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-1fa13034581ea540bb94760ef201f58659e06e6e9db04d2799767c45d30251063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2438734735&rft_id=info:pmid/30464809&rfr_iscdi=true